Home | Business News | Browse by Publication | M | M2 Presswire

MedImmune In-Licenses Novel Inflammatory Disease Target and The Year in Review, Celgene Corp.

Publication: M2 Presswire
Publication Date: 29-DEC-06
Format: Online
Delivery: Immediate Online Access

Article Excerpt
M2 PRESSWIRE-29 December 2006-U.S. Equity News: MedImmune In-Licenses Novel Inflammatory Disease Target and The Year in Review, Celgene Corp.(C)1994-2006 M2 COMMUNICATIONS LTD

RDATE:29122006

City of Industry, CA - Biotechnology industry alert provided by U.S. Equity News. MedImmune, Inc. (Nasdaq: MEDI) recently announced that it intends to develop a monoclonal antibody (MAb) targeting pathways within the CD28 receptor family for treatment of certain inflammatory diseases under a recently signed license agreement with Japan...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from M2 Presswire
Defra opens up Bio-Energy capital grants scheme third round - support ..., December 29, 2006
BWR Begins Tracking Inspiration Mining Corporation., December 29, 2006
GBRC, HRCT, AAGH, GOFH - OTCStockExchange.com Stock Alert., December 29, 2006
Speak with other shareholders about: (OTCBB:FLIP) (OTCBB:SEVT) (OTCBB:..., December 29, 2006
Univision President Exercises Options and Eminem to Host New Year's Ev..., December 29, 2006

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.